logo
Select company
Select metric
0%Goodwill & Intangibles to Assets Ratio
VS
Market
-
Sector
-
Industry
-
History
-
$ 15.19Close
$ 9.55 - $ 70 52-Week Range
Ticker Information

Ticker

KROS

Company Name

KEROS THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KEROS THERAPEUTICS INC - Goodwill & Intangibles to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KROS - Intang. to Assets Historical data
DateTotal AssetsGoodwill and IntangiblesGoodwill & Intangibles to Assets Ratio
6/30/2025$ 757.16M$ 00%
3/31/2025$ 784.56M$ 00%
12/31/2024$ 615.89M$ 00%
9/30/2024$ 579.27M$ 00%
6/30/2024$ 455.02M$ 00%
3/31/2024$ 485.82M$ 00%
12/31/2023$ 370.02M$ 00%
9/30/2023$ 326.25M$ 00%
6/30/2023$ 356.31M$ 00%
3/31/2023$ 384.44M$ 00%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KEROS THERAPEUTICS INC's latest trailing twelve months (TTM) Intang. to Assets stands at 0%.
  • Over the past 5 years, KEROS THERAPEUTICS INC's average Intang. to Assets has been 0%.
  • The median Intang. to Assets for KEROS THERAPEUTICS INC during this period was 0%
  • KEROS THERAPEUTICS INC reached its highest Intang. to Assets over the past 5 years at 0%.
  • The lowest Intang. to Assets recorded by KEROS THERAPEUTICS INC in the same timeframe 0%

KEROS THERAPEUTICS INC's Intang. to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Intang. to Assets Benchmarks
CompanyIntang. to Assets
MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 35.95%DNA : GINKGO BIOWORKS HOLDINGS INC 5.37%DAWN : DAY ONE BIOPHARMACEUTICALS INC 3.78%RIGL : RIGEL PHARMACEUTICALS INC 12.54%STOK : STOKE THERAPEUTICS INC 0%XNCR : XENCOR INC 1.28%AKBA : AKEBIA THERAPEUTICS INC 17.08%ANAB : ANAPTYSBIO INC 0%RGNX : REGENXBIO INC 0%PHAT : PHATHOM PHARMACEUTICALS INC 0%

Definition of Goodwill & Intangibles to Assets Ratio

[Calculation] The [Intangibles] to [Assets] ratio is used as a company valuation factor by investors. Goodwill & Intangibles represent hard-to-value assets like a company’s brand name, solid customer relations, intellectual property, etc.
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for KEROS THERAPEUTICS INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 138.25M ]
(=) Intang. to Assets [ 0% ]

KROS - Goodwill & Intangibles to Assets Ratio, Last 5 years

0%

Minimum

Sep 30, 2020

0%

Maximum

Sep 30, 2020

0%

Average

0%

Median

Intang. to Assets Benchmark Analysis

The chart above depicts the distribution of Intang. to Assets for companies in the Total Stock Market. The average Intang. to Assets of the companies is 3.98% with a standard deviation of 6.09%.
The following table provides additional summary stats:
Intang. to Assets in the Market:
filtered constituents3.24K
min0%
max23.16%
average3.98%
median0.52%
std6.09%